Tuesday, November 22, 2016

Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients


by Colin R. Lenihan, Sumi Sukumaran Nair, Chandan Vangala, Venkat Ramanathan, Maria E. Montez-Rath, Wolfgang C. Winkelmayer
Posttransplantation bone disease is a significant problem, with few well-evidenced therapeutic options. Proton pump inhibitors (PPIs) are associated with hip fracture in the general population and are widely prescribed for kidney transplant recipients.

Shared via Inoreader

Enviado desde mi iPad

No comments:

Post a Comment